When an Underactive Thyroid Actually Needs Treatment

Not every low or borderline thyroid number warrants treatment. The decision depends on how low TSH is, what the thyroid hormone levels look like, whether symptoms are present, and who the patient is. There are situations where the answer is clear, and situations where it's genuinely more nuanced.

Generally treat

  • TSH elevated and free T4 below normal (overt hypothyroidism)
  • TSH above 10 mIU/L, even if free T4 is still normal
  • Pregnancy or trying to conceive — TSH target tightens to <2.5 mIU/L
  • Symptomatic patients under 65 with TSH between 4–10 mIU/L

More nuanced

  • TSH mildly elevated (4–10 mIU/L) with normal T4 and no symptoms — evidence of benefit is limited
  • Older adults (≥65): a slightly elevated TSH may actually be protective; risks of overtreatment increase with age
  • Isolated fatigue or weight gain with normal TSH — treatment is not indicated and unlikely to help
📊 The Evidence The gray zone — a TSH between 4 and 10 with normal T4, called subclinical hypothyroidism (SCH) — affects roughly 3–8% of the population and is where most of the controversy lives. Multiple trials of levothyroxine in older adults with SCH have found no meaningful improvement in quality of life, fatigue, cognitive function, or mood scores compared to placebo.[1] A large 2017 trial specifically in older adults found no benefit on any patient-reported outcome.[2] Guidelines now recommend against routine treatment in adults over 65 with mildly elevated TSH, and are cautious even in younger patients without symptoms.[1]
My Synthesis For patients who are already on treatment, the goal isn't a single magic TSH number — it's finding the right target within the safe range for that individual. The reference range runs from 0.5 to 4.0 mIU/L, and in my experience there is real variability in where patients feel their best within that window. Some feel noticeably better with a TSH closer to 1; others do fine closer to 3. I work with patients to adjust the dose within the safe range and see whether they notice a difference — while being careful not to push below 0.5, where the risks of overtreatment become meaningful. What I'm not doing is chasing an arbitrary "optimal" number that someone read about online. The target is the range where you feel well and your labs are safe.

Levothyroxine: The Standard Treatment

When treatment is indicated, the standard medication is levothyroxine (brand names include Synthroid, Levoxyl, Tirosint) — a synthetic version of T4, the main hormone the thyroid produces naturally. The body converts it to the active form, T3, the same way it would convert the real thing. It's taken as a single daily pill, ideally on an empty stomach 30–60 minutes before breakfast, since food and certain supplements can interfere with absorption.

Dosing is individualized based on weight, age, and the cause of hypothyroidism, then adjusted based on TSH levels checked 6–8 weeks after any dose change. The goal is a TSH within the normal reference range — generally 0.4–4.0 mIU/L — not a specific number within that range. I'll come back to the "optimal TSH" question in Post 1.4, where it belongs alongside the other wellness industry claims.

One Practical Note on Timing

If you're on levothyroxine and getting labs done, take your blood draw before your morning dose rather than after. Thyroid hormone levels rise transiently — up to 20% — in the hours after taking the pill.[3] Drawing blood after dosing can make your free T4 look higher than your actual steady-state level and could lead to an unnecessary dose reduction.

Brand vs. Generic — Why It Matters More for This Drug

Levothyroxine is one of the few medications where I recommend picking a specific brand or generic product and sticking with it — rather than accepting whatever version the pharmacy dispenses that month. Here's why.

The FDA allows generic medications to have bioavailability (the amount of active drug your body actually absorbs) anywhere between 80% and 125% of the labeled dose compared to the brand-name reference standard. For most medications, that range is clinically unimportant. For levothyroxine, it can matter. Because the therapeutic window is narrow — the difference between too little and too much is meaningful — switching between manufacturers while staying on the "same dose" can effectively change how much hormone you're absorbing. That can be enough to shift your TSH noticeably and bring back symptoms, even when the pill bottle says the same number of micrograms.

This isn't unique to thyroid medication. A 2025 ProPublica investigation found that the FDA's generic drug equivalence rules can result in patients receiving meaningfully different amounts of active drug than expected — with serious consequences in narrow-therapeutic-index medications like the anti-rejection drug tacrolimus. The same principle applies here, though for most levothyroxine patients the practical risk is feeling off for a few weeks rather than anything more serious.[*]

⚠ Practical Recommendation Ask your pharmacy to dispense the same manufacturer's version of levothyroxine each time — or stay on a brand-name product consistently. If your prescription changes to a different manufacturer and your symptoms return or your TSH shifts, that's worth flagging. It may not be your thyroid changing — it may be the medication's absorption that changed.

Does Thyroid Hormone Help With Weight Loss?

This is one of the most common questions I hear, and the answer is direct: no, not in people with normal thyroid function — and trying to use it that way carries serious risks.

⚠ Black Box Warning

The FDA requires the following warning on all thyroid hormone medications: levothyroxine should not be used for the treatment of obesity or weight loss. Larger doses produce serious or even life-threatening side effects, particularly when combined with other weight loss agents.[4][5]

Risks of thyroid hormone taken above what the body needs include: heart rhythm problems (arrhythmias), heart attack, heart failure, chest pain (angina), decreased bone density leading to fractures, muscle weakness, and neuropsychiatric symptoms including anxiety and insomnia.[4][5]

📊 The Evidence

Physiologic doses of levothyroxine — meaning doses within the range of normal daily thyroid production — do not cause weight loss in people with normal thyroid function.[4] A 12-month study of TSH suppression therapy in euthyroid patients found no changes in weight, body fat, waist circumference, or exercise capacity compared to untreated patients.[4]

Here's what's also worth knowing about weight and true hypothyroidism: most of the weight gained with an underactive thyroid is fluid retention, not fat. Even after treating severe hypothyroidism, there is no significant loss of fat mass, despite improvements in metabolism.[4] And treating subclinical hypothyroidism — the mildly elevated TSH range — produces no meaningful change in body weight at all.[4] A 2026 review confirmed that deliberately inducing a hyperthyroid state for weight loss, whether in hypothyroid patients or otherwise, has not proven effective.[6]

There is also an important reverse relationship: obesity itself can raise TSH slightly, making it look like a thyroid problem when the thyroid is actually fine. TSH often normalizes with weight loss — without any thyroid treatment.[4]

My Synthesis When a patient asks me about thyroid hormone for weight loss, my first concern is their safety. The black box warning exists for real reasons — I've seen patients come in after obtaining thyroid medication from wellness clinics with heart palpitations, anxiety, and insomnia from taking doses well above what their body needs. The weight didn't come off. The side effects were very real. Beyond the safety issue, treating a normal thyroid to fix a weight problem also misses whatever is actually driving the weight gain. That deserves its own proper evaluation.

Can You Take Levothyroxine Once a Week?

This question comes up more than you might expect, usually from patients who struggle with daily medication adherence. The short answer is: yes, in select situations — but it's a fallback, not a preference.

Levothyroxine has a long half-life of 6–7 days, which means it stays in the body for a substantial time after each dose. This pharmacology makes weekly dosing theoretically feasible, and the American Thyroid Association says weekly oral dosing — taking all seven days' worth at once — can be considered when daily adherence genuinely cannot be maintained.[3]

📊 The Evidence A 2025 meta-analysis of three randomized trials found that weekly levothyroxine resulted in slightly higher average TSH levels compared to daily dosing — a difference of about 1.14 mIU/L — though average TSH remained within the normal range in both groups.[7] The catch is a predictable spike: T4 levels rise significantly for about 24 hours after the weekly dose, which could theoretically cause temporary symptoms of too much thyroid hormone — palpitations, anxiety, feeling overheated. In practice, short-term trials found no differences in heart rate, cardiac function, bone markers, or patient wellbeing between weekly and daily dosing, though cholesterol was modestly higher with weekly therapy.[3] Twice-weekly dosing is another option that produces more stable levels and may be a reasonable middle ground.[3]

The dose for weekly administration is simply seven times the daily dose — so a patient who would take 100 mcg daily would take 700 mcg once weekly. It's worth noting that the trials supporting this approach were short-term and weren't specifically conducted in patients who had previously struggled with daily adherence. If adherence is the issue, it's also worth exploring why before changing the regimen — timing, cost, and pill burden are all addressable.

⚠ Missed a Dose? Here's What to Do The long half-life of levothyroxine makes it one of the most forgiving medications to miss. If you forget one day's dose — or even two or three — you can simply take all the missed pills at once and then resume your normal daily schedule. Because the drug stays active in your body for nearly a week, occasional gaps don't cause the kind of rapid symptom return you'd see with shorter-acting medications.

Liothyronine (T3 medication) is a different story. Its half-life is only about one day, which means levels drop off much more quickly. Liothyronine requires consistent daily dosing — sometimes split into two doses per day — to maintain stable levels. Missing doses matters more, and doubling up to catch up isn't recommended in the same way.

The T3 Debate: Should Combination Therapy Be Added?

This is probably the most common thyroid controversy patients bring up, often after reading about it online or hearing about it from a wellness provider. The argument goes: levothyroxine only replaces T4, but some people don't convert T4 to T3 efficiently — so shouldn't we just add T3 (liothyronine, brand name Cytomel) directly?

It's a physiologically reasonable question. And the evidence gives a nuanced answer — not a flat no, but not a broad yes either.

📊 The Evidence

Eighteen randomized controlled trials and four systematic reviews have compared combination levothyroxine plus liothyronine therapy against levothyroxine alone. For the overall population of hypothyroid patients, no clear benefit was found in mood, quality of life, or cognitive function.[1] These trials had real limitations — small sample sizes, doses that were likely too high or given only once daily rather than split — which means a negative result doesn't fully close the door.

Where the evidence gets more interesting is in symptomatic patients — those who are biochemically normal on levothyroxine but still feel unwell. A 2021 three-arm trial comparing levothyroxine alone, levothyroxine plus liothyronine, and desiccated thyroid extract found that among the one-third of patients who were most symptomatic on levothyroxine, there was a strong preference for T3-containing therapy, with improvements in thyroid symptom scores, quality of life, depression, and memory.[8] A 2025 meta-analysis confirmed that 52% of patients preferred combination therapy vs. 24% preferring levothyroxine alone.[9]

There's also a physiologic observation worth noting: people on levothyroxine monotherapy tend to have T3 levels toward the lower end of the normal range, and are 54% more likely to be taking a statin than matched controls with normal thyroid function — suggesting their metabolism may not be fully normalized despite a normal TSH.[1]

What About Desiccated Thyroid Extract?

Desiccated thyroid extract (DTE) — dried pig thyroid gland, sold under brand names like Armour Thyroid and NP Thyroid — contains both T4 and T3, which is part of its appeal. The evidence on how it compares to levothyroxine is worth understanding clearly, because the picture is more nuanced than either its enthusiasts or critics often present.

📊 The Evidence — Desiccated Thyroid

Head-to-head randomized trials show that DTE performs equivalently to levothyroxine on objective measures: quality of life questionnaires, symptom scores, depression inventories, and cognitive testing.[8][15] Despite those equivalent outcomes, patient preference strongly favors DTE — in a 2013 crossover trial, 48.6% of patients preferred DTE vs. 18.6% who preferred levothyroxine, with the remainder having no preference.[15] The same pattern of symptomatic patients doing better on T3-containing therapy held here as in the levothyroxine plus liothyronine trials.[8]

The concern with DTE is the T4:T3 ratio. Pig thyroid contains T4 and T3 in a ratio of about 4:1. The human thyroid produces them in a ratio closer to 14:1. That means DTE delivers substantially more T3 relative to T4 than the body is designed to handle — and because T3 has a short half-life, levels spike after each dose and then fall, producing fluctuations throughout the day. Studies have documented modest but measurable increases in heart rate with DTE use.[8] The American Thyroid Association recommends against DTE as routine care, citing supraphysiologic T3 levels and the absence of long-term safety data.[4]

What the Guidelines Actually Say

The 2023 joint British Thyroid Association and Society for Endocrinology consensus statement offers a careful middle ground: for carefully selected patients with confirmed overt hypothyroidism who remain symptomatic despite adequate levothyroxine treatment — with TSH between 0.3 and 2.0 mIU/L for at least 3–6 months, and after ruling out other causes of their symptoms — a trial of combination therapy may be appropriate through shared decision-making.[10]

The starting approach, when combination therapy is tried, is to reduce the levothyroxine dose by 25 mcg per day and add a small dose of liothyronine — 2.5 to 7.5 mcg, ideally split into two doses per day rather than one.[11] Liothyronine alone, without levothyroxine, is not recommended because of difficulty maintaining stable T3 levels throughout the day.[1]

The Safety Question

Liothyronine has a shorter half-life than levothyroxine — about one day versus seven — which means T3 levels fluctuate more between doses. This makes it easier to accidentally overshoot into hyperthyroid territory, at least transiently, which is why careful dosing and monitoring matter more with combination therapy than with levothyroxine alone.

📊 The Evidence — Safety of Liothyronine A 2025 meta-analysis of over 630,000 patients found no increased risk of atrial fibrillation, heart failure, or stroke with liothyronine use, and actually observed lower mortality in liothyronine users.[12] A 17-year observational study of 400 patients on combination therapy found no increased risk of cardiovascular disease, atrial fibrillation, or fractures compared to levothyroxine-only users.[13] One Asian cohort study found elevated risks of heart failure and stroke in liothyronine users — particularly with longer duration of use — which requires confirmation in other populations before drawing firm conclusions.[14]
My Synthesis In my practice I use levothyroxine almost exclusively — the evidence base is the strongest, dosing is predictable, and the vast majority of my patients do well on it. For the small number of patients who remain genuinely symptomatic despite a well-optimized TSH and after ruling out other causes, a carefully supervised trial of liothyronine added to levothyroxine is a conversation I'm willing to have.

I don't typically recommend desiccated thyroid extract, and the main reason is consistency. Beyond the T4:T3 ratio problem, the amount of thyroid hormone in DTE varies between animal batches — meaning the dose you get this month may not be the dose you get next month, even from the same bottle. For a medication that requires careful titration within a narrow range, that variability makes precise adjustments difficult. The same logic drives my recommendation to stick with one manufacturer of levothyroxine: predictability matters when you're trying to dial in a dose. What I'm not willing to do with any of these medications is push T3 levels into supraphysiologic territory in the name of optimization — the cardiac and bone risks are real, and the evidence doesn't support it.